Recordati Rare Diseases Inc.
Overview
Recordati Rare Diseases Inc. is a subsidiary of Recordati S.p.A., focusing on the research and development of treatments for rare and orphan diseases. The company is committed to providing novel therapies to improve the lives of patients living with these conditions.
Therapeutic areas
API / Drug Master Files
Recordati Rare Diseases Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- DINUTUXIMAB BETA (APN311)Active2019-05-02
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Recordati Rare Diseases Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.